Abstract:A growing number of studies have demonstrated the role of post-translational modifications of proteins, particularly acetylation, in human diseases including neurodegenerative and cardiovascular diseases, diabetes, cancer, and in aging. Acetylation of mitochondrial proteins has been shown to be involved in the pathogenesis of cardiac diseases such as myocardial infarction (ischemia-reperfusion) and heart failure. Indeed, over 60% of mitochondrial proteins contain acetylation sites, and most of these proteins are involved in mitochondrial bioenergetics. Mitochondrial non-enzymatic acetylation is enabled by acetyl-coenzyme A abundance and serves as the primary pathway of acetylation in mitochondria. Hence, regulation of enzymatic deacetylation becomes the most important mechanism to control acetylation/deacetylation of mitochondrial proteins. Acetylation/deacetylation of mitochondrial proteins has been regarded as a key regulator of mitochondrial metabolism and function. Proteins are deacetylated by NAD+-dependent deacetylases known as sirtuins (SIRTs). Among seven sirtuin isoforms, only SIRT3, SIRT4, and SIRT5 are localized in the mitochondria. SIRT3 is the main mitochondrial sirtuin which plays a key role in maintaining metabolic and redox balance in the mitochondria under physiological and pathological conditions. SIRT3 regulates the enzymatic activity of proteins involved in fatty acid oxidation, tricarboxylic acid cycle, electron transport chain, and oxidative phosphorylation. Although many enzymes have been identified as targets for SIRT3, cardiac-specific SIRT3 effects and regulations could differ from those in non-cardiac tissues. Therefore, it is important to elucidate the contribution of SIRT3 and mitochondrial protein acetylation/deacetylation in mitochondrial metabolism and cardiac dysfunction. Here, we summarize previous studies and provide a comprehensive analysis of the role of SIRT3 in mitochondria metabolism and bioenergetics under physiological conditions and in cardiac diseases. In addition, the review discusses mitochondrial protein acetylation as a potential target for cardioprotection.

The role of SIRT3 in homeostasis and cellular health

A Role for the Mitochondrial Deacetylase Sirt3 in Regulating Energy Homeostasis.

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target

The Role of SIRT3-mediated Mitochondrial Homeostasis in Osteoarthritis

SIRT3 involved in protecting heart by regulating mitochondrial protein deacetylation

Mitochondrial Sirtuins and Their Relationships with Metabolic Disease and Cancer

Roles of SIRT3 in Heart Failure: from Bench to Bedside.

Emerging role of SIRT3 in endothelial metabolism, angiogenesis, and cardiovascular disease

SIRT3: A New Regulator of Cardiovascular Diseases

Mitochondrial Sirtuin Network Reveals Dynamic SIRT3-Dependent Deacetylation in Response to Membrane Depolarization

Mitochondrial sirtuin 3 and role of natural compounds: the effect of post-translational modifications on cellular metabolism

The relationship of SIRT3 with cellular metabolism and cardiovascular diseases

Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3

SIRT3 Deacetylates ATP Synthase F1 Complex Proteins in Response to Nutrient- and Exercise-Induced Stress.

The Role of SIRT3 in Exercise and Aging

Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast.

Role of SIRT3 in Bone Homeostasis and Its Application in Preventing and Treating Bone Diseases

SIRT3 Protein Deacetylates Isocitrate Dehydrogenase 2 (IDH2) and Regulates Mitochondrial Redox Status

Advances in SIRT3 involvement in regulating autophagy-related mechanisms

Mitochondrial Sirtuins in cardiometabolic diseases.

Role of Sirtuin 3 in Degenerative Diseases of the Central Nervous System